Ahmed Hamdy

Ahmed M.
Hamdy was the founder of Vincerx Pharma, Inc., founded in 2018, where the title held was Chairman & Chief Executive Officer from 2021 to 2024.
Dr. Hamdy is also the founder of Acerta Pharma BV,Acerta Pharma LLC.
Current jobs include Independent Director at Andes Biotechnologies SA since 2016, Director & Clinical Advisor at Andes Biotechnologies Global, Inc. since 2016, Member-Presidents Council at The Palo Alto Medical Foundation since 2016, Member-Deans Council at Baskin School of Engineering since 2019, and Chief Medical Officer at Curis, Inc. starting in 2025.
Former jobs include Medical Director at ALZA Corp.
in 2006, Medical Director at Johnson & Johnson in 2006, Senior Principal Scientist at Actavis, Inc. in 2004, Chief Medical Officer at Pharmacyclics LLC from 2008 to 2011, and Head-Early Clinical Development at AstraZeneca PLC from 2016 to 2019.
Education includes a doctorate from the University of Cairo and an undergraduate degree from KasrAlAiny School of Medicine.